Qiao J - Search Results

1

DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor Immunity.

Lu C, Guan J, Lu S, Jin Q, Rousseau B, Lu T, Stephens D, Zhang H, Zhu J, Yang M, Ren Z, Liang Y, Liu Z, Han C, Liu L, Cao X, Zhang A, Qiao J, Batten K, Chen M, Castrillon DH, Wang T, Li B, Diaz LA Jr, Li GM, Fu YX. Lu C, et al. Among authors: qiao j. Cancer Cell. 2021 Jan 11;39(1):96-108.e6. doi: 10.1016/j.ccell.2020.11.006. Epub 2020 Dec 17. Cancer Cell. 2021. PMID: 33338425 Free PMC article.

2

Immunotherapy and tumor microenvironment.

Tang H, Qiao J, Fu YX. Tang H, et al. Among authors: qiao j. Cancer Lett. 2016 Jan 1;370(1):85-90. doi: 10.1016/j.canlet.2015.10.009. Epub 2015 Oct 19. Cancer Lett. 2016. PMID: 26477683 Free PMC article. Review.

3

Adapting conventional cancer treatment for immunotherapy.

Qiao J, Liu Z, Fu YX. Qiao J, et al. J Mol Med (Berl). 2016 May;94(5):489-95. doi: 10.1007/s00109-016-1393-4. Epub 2016 Feb 24. J Mol Med (Berl). 2016. PMID: 26910191 Review.

4

DNA sensing and immune responses in cancer therapy.

Qiao J, Tang H, Fu YX. Qiao J, et al. Curr Opin Immunol. 2017 Apr;45:16-20. doi: 10.1016/j.coi.2016.12.005. Epub 2017 Jan 12. Curr Opin Immunol. 2017. PMID: 28088707 Review.

5

Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.

Tang H, Zhu M, Qiao J, Fu YX. Tang H, et al. Among authors: qiao j. Cell Mol Immunol. 2017 Oct;14(10):809-818. doi: 10.1038/cmi.2017.13. Epub 2017 Apr 17. Cell Mol Immunol. 2017. PMID: 28413217 Free PMC article. Review.

6

PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression.

Tang H, Liang Y, Anders RA, Taube JM, Qiu X, Mulgaonkar A, Liu X, Harrington SM, Guo J, Xin Y, Xiong Y, Nham K, Silvers W, Hao G, Sun X, Chen M, Hannan R, Qiao J, Dong H, Peng H, Fu YX. Tang H, et al. Among authors: qiao j. J Clin Invest. 2018 Feb 1;128(2):580-588. doi: 10.1172/JCI96061. Epub 2018 Jan 16. J Clin Invest. 2018. PMID: 29337303 Free PMC article.

7

Targeting Tumors with IL-10 Prevents Dendritic Cell-Mediated CD8⁺ T Cell Apoptosis.

Qiao J, Liu Z, Dong C, Luan Y, Zhang A, Moore C, Fu K, Peng J, Wang Y, Ren Z, Han C, Xu T, Fu YX. Qiao J, et al. Cancer Cell. 2019 Jun 10;35(6):901-915.e4. doi: 10.1016/j.ccell.2019.05.005. Cancer Cell. 2019. PMID: 31185213 Free article.

8

NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance.

Li X, Liu Z, Zhang A, Han C, Shen A, Jiang L, Boothman DA, Qiao J, Wang Y, Huang X, Fu YX. Li X, et al. Among authors: qiao j. Nat Commun. 2019 Jul 19;10(1):3251. doi: 10.1038/s41467-019-11238-1. Nat Commun. 2019. PMID: 31324798 Free PMC article.

9

Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity.

Liu Z, Han C, Dong C, Shen A, Hsu E, Ren Z, Lu C, Liu L, Zhang A, Timmerman C, Pu Y, Wang Y, Chen M, Qiao J, Fu YX. Liu Z, et al. Among authors: qiao j. Sci Immunol. 2019 Aug 9;4(38):eaav6473. doi: 10.1126/sciimmunol.aav6473. Sci Immunol. 2019. PMID: 31399492

10

Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers.

Zhang H, Liu L, Zhang J, Chen J, Ye J, Shukla S, Qiao J, Zhan X, Chen H, Wu CJ, Fu YX, Li B. Zhang H, et al. Among authors: qiao j. Clin Cancer Res. 2020 Mar 15;26(6):1359-1371. doi: 10.1158/1078-0432.CCR-19-3249. Epub 2019 Dec 12. Clin Cancer Res. 2020. PMID: 31831563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,088 results

Search Page